These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 38229578)
1. A potent multifunctional ZIF-8 nanoplatform developed for colorectal cancer therapy by triple-delivery of chemo/radio/targeted therapy agents. Iranpour S; Bahrami AR; Dayyani M; Saljooghi AS; Matin MM J Mater Chem B; 2024 Jan; 12(4):1096-1114. PubMed ID: 38229578 [TBL] [Abstract][Full Text] [Related]
2. Improving anti-cancer drug delivery performance of magnetic mesoporous silica nanocarriers for more efficient colorectal cancer therapy. Iranpour S; Bahrami AR; Nekooei S; Sh Saljooghi A; Matin MM J Nanobiotechnology; 2021 Oct; 19(1):314. PubMed ID: 34641857 [TBL] [Abstract][Full Text] [Related]
3. Metal-Organic Framework/Graphene Quantum Dot Nanoparticles Used for Synergistic Chemo- and Photothermal Therapy. Tian Z; Yao X; Ma K; Niu X; Grothe J; Xu Q; Liu L; Kaskel S; Zhu Y ACS Omega; 2017 Mar; 2(3):1249-1258. PubMed ID: 30023630 [TBL] [Abstract][Full Text] [Related]
4. Graphene quantum dots-gated hollow mesoporous carbon nanoplatform for targeting drug delivery and synergistic chemo-photothermal therapy. Fang J; Liu Y; Chen Y; Ouyang D; Yang G; Yu T Int J Nanomedicine; 2018; 13():5991-6007. PubMed ID: 30323587 [TBL] [Abstract][Full Text] [Related]
5. Synthesis of doxorubicin-loaded peptosomes hybridized with gold nanorod for targeted drug delivery and CT imaging of metastatic breast cancer. Hasannia M; Abnous K; Taghdisi SM; Nekooei S; Ramezani M; Alibolandi M J Nanobiotechnology; 2022 Aug; 20(1):391. PubMed ID: 36045404 [TBL] [Abstract][Full Text] [Related]
6. Enhanced theranostic efficacy of epirubicin-loaded SPION@MSN through co-delivery of an anti-miR-21-expressing plasmid and ZIF-8 hybridization to target colon adenocarcinoma. Abrishami A; Bahrami AR; Saljooghi AS; Matin MM Nanoscale; 2024 Mar; 16(12):6215-6240. PubMed ID: 38446130 [TBL] [Abstract][Full Text] [Related]
7. Hybrid silica-coated Gd-Zn-Cu-In-S/ZnS bimodal quantum dots as an epithelial cell adhesion molecule targeted drug delivery and imaging system. Akbarzadeh M; Babaei M; Abnous K; Taghdisi SM; Peivandi MT; Ramezani M; Alibolandi M Int J Pharm; 2019 Oct; 570():118645. PubMed ID: 31465835 [TBL] [Abstract][Full Text] [Related]
8. Zeolitic Imidazolate Framework (ZIF-8) Decorated Iron Oxide Nanoparticles Loaded Doxorubicin Hydrochloride for Osteosarcoma Treatment - in vitro and in vivo Preclinical Studies. Wu W; Yu X; Sun J; Han Y; Ma Y; Zhang G; Ma Q; Li Q; Xiang H Int J Nanomedicine; 2023; 18():7985-7999. PubMed ID: 38164268 [TBL] [Abstract][Full Text] [Related]
9. Epithelial cell adhesion molecule aptamer functionalized PLGA-lecithin-curcumin-PEG nanoparticles for targeted drug delivery to human colorectal adenocarcinoma cells. Li L; Xiang D; Shigdar S; Yang W; Li Q; Lin J; Liu K; Duan W Int J Nanomedicine; 2014; 9():1083-96. PubMed ID: 24591829 [TBL] [Abstract][Full Text] [Related]
10. Folic Acid Decorated Zeolitic Imidazolate Framework (ZIF-8) Loaded with Baicalin as a Nano-Drug Delivery System for Breast Cancer Therapy. Mi X; Hu M; Dong M; Yang Z; Zhan X; Chang X; Lu J; Chen X Int J Nanomedicine; 2021; 16():8337-8352. PubMed ID: 34992370 [TBL] [Abstract][Full Text] [Related]
11. EpCAM aptamer-functionalized polydopamine-coated mesoporous silica nanoparticles loaded with DM1 for targeted therapy in colorectal cancer. Li Y; Duo Y; Bao S; He L; Ling K; Luo J; Zhang Y; Huang H; Zhang H; Yu X Int J Nanomedicine; 2017; 12():6239-6257. PubMed ID: 28894364 [TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo evaluation of therapy targeting epithelial-cell adhesion-molecule aptamers for non-small cell lung cancer. Alibolandi M; Ramezani M; Abnous K; Sadeghi F; Atyabi F; Asouri M; Ahmadi AA; Hadizadeh F J Control Release; 2015 Jul; 209():88-100. PubMed ID: 25912964 [TBL] [Abstract][Full Text] [Related]
13. Harnessing curcumin in a multifunctional biodegradable metal-organic framework (bio-MOF) for targeted colorectal cancer theranostics. Babaei M; Abrishami A; Iranpour S; Saljooghi AS; Matin MM Drug Deliv Transl Res; 2024 Sep; ():. PubMed ID: 39302530 [TBL] [Abstract][Full Text] [Related]
14. Dual ATP and pH responsive ZIF-90 nanosystem with favorable biocompatibility and facile post-modification improves therapeutic outcomes of triple negative breast cancer in vivo. Jiang Z; Wang Y; Sun L; Yuan B; Tian Y; Xiang L; Li Y; Li Y; Li J; Wu A Biomaterials; 2019 Mar; 197():41-50. PubMed ID: 30640136 [TBL] [Abstract][Full Text] [Related]
15. Targeted delivery of elesclomol using a magnetic mesoporous platform improves prostate cancer treatment both in vitro and in vivo. Tarin M; Babaei M; Eshghi H; Matin MM; Saljooghi AS Talanta; 2024 Apr; 270():125539. PubMed ID: 38141466 [TBL] [Abstract][Full Text] [Related]
16. Precision Treatment of Colon Cancer Using Doxorubicin-Loaded Metal-Organic-Framework-Coated Magnetic Nanoparticles. Jiang H; Bao Q; Yang T; Yang M; Mao C ACS Appl Mater Interfaces; 2024 Sep; 16(37):49003-49012. PubMed ID: 39226043 [TBL] [Abstract][Full Text] [Related]
17. Biodegradable Imprinted Polymer Based on ZIF-8/DOX-HA for Synergistically Targeting Prostate Cancer Cells and Controlled Drug Release with Multiple Responses. Song Y; Han S; Liu S; Sun R; Zhao L; Yan C ACS Appl Mater Interfaces; 2023 May; 15(21):25339-25353. PubMed ID: 37212295 [TBL] [Abstract][Full Text] [Related]
18. Epithelial cell adhesion molecule aptamer conjugated PEG-PLGA nanopolymersomes for targeted delivery of doxorubicin to human breast adenocarcinoma cell line in vitro. Alibolandi M; Ramezani M; Sadeghi F; Abnous K; Hadizadeh F Int J Pharm; 2015 Feb; 479(1):241-51. PubMed ID: 25529433 [TBL] [Abstract][Full Text] [Related]
19. Glycyrrhetinic Acid Receptor-Mediated Zeolitic Imidazolate Framework-8 Loaded Doxorubicin as a Nanotherapeutic System for Liver Cancer Treatment. Mi X; Lou Y; Wang Y; Dong M; Xue H; Li S; Lu J; Chen X Molecules; 2023 Dec; 28(24):. PubMed ID: 38138618 [TBL] [Abstract][Full Text] [Related]
20. Ligand-Modified Erythrocyte Membrane-Cloaked Metal-Organic Framework Nanoparticles for Targeted Antitumor Therapy. Lin Y; Zhong Y; Chen Y; Li L; Chen G; Zhang J; Li P; Zhou C; Sun Y; Ma Y; Xie Z; Liao Q Mol Pharm; 2020 Sep; 17(9):3328-3341. PubMed ID: 32804508 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]